Conservative Management of Uterine Adenomyosis: Medical vs. Surgical Approach
Open accessThe DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Abstract
Uterine adenomyosis is a commonly encountered estrogen-dependent disease in reproductive-age women, causing heavy menstrual bleeding, intense pelvic pain, and infertility. Although adenomyosis was previously considered a disease of multiparous women, it is becoming increasingly evident that it also affects younger nulliparous women and may compromise their fertility potential. It is clear that hysterectomy, the standard approach to definitively manage the disease, is not an option for patients wishing to preserve their fertility, so there is an urgent need to develop novel conservative strategies. We searched the current literature for available methods for conservative management of adenomyosis, including both pharmacological and surgical approaches. There is no existing drug that can cure adenomyosis at present, but some off-label treatment options may be used to tackle disease symptoms and improve fertility outcomes. Adenomyosis in patients wishing to conceive can be ‘treated’ by conservative surgery, though these procedures require highly experienced surgeons and pose a considerable risk of uterine rupture during subsequent pregnancies. While currently available options for conservative management of adenomyosis do have some capacity for alleviating symptoms and enhancing patient fertility perspectives, more effective new options are needed, with gonadotropin-releasing hormone antagonists showing encouraging results in preliminary studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Schematic representation of the triple-flap method applied to the anterior and posterior uterine wall. The approach involves complete extraction of the uterine adenomyosis (A–C), followed by reconstruction of the uterine cavity (D–F). An endometrial uterine muscle flap is created by metroplasty and uterine muscle located on the serosal side is used to fill the large uterine wall muscle defect (E,F) (reprinted with permission from [95]).](https://figures.cochat.ai/paper-figures/1fab60a6d4ed43bf9942d9a5f3100fd1/conservative-management-of-uterine-adenomyosis-medical-vs-surgical-approach-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“adenomyosis (AD) and certain subtypes of endometriosis, such as deep endometriosis (DE), do not respond to hormonal treatment as well as ovarian endometrioma (OE) (Stratopoulou et al., 2021; Vannuccini et al., 2022)”
From Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium (2025) · cites this paper as Stratopoulou et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nisolle, M., & Donnez, J. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00191-x · Cited by 1,279 · cited 1×
“Impaired stromal decidualization may constitute another reason, given the frequently encountered resistance to progesterone in adenomyosis patients, a hormone playing a pivotal role in the transition of endometrium to its decidualized state [1,15,82,83].”
BackgroundSelf-citationWhat we know about primary dysmenorrhea today: a critical review
Iacovides, S., Avidon, I., & Baker, F. C. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv039 · Cited by 1,022 · cited 2×
“NSAIDs block cyclooxygenase, suppress prostaglandin, and alleviate uterine hypercontractility, so they relieve pain without treating potential underlying causes, as in case of adenomyosis and endometriosis [8].”
BackgroundUlipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Donnez, J., Tatarchuk, T. F., Bouchard, P., Puscasiu, L., Zakharenko, N. F., Ivanova, T., Ugocsai, G., Mara, M., Jilla, M. P., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103182 · Cited by 680
Self-citationNonsteroidal anti-inflammatory drugs for dysmenorrhoea
Marjoribanks, J., Ayeleke, R. O., Farquhar, C., & Proctor, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001751.pub3 · Cited by 562
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., Diamond, M. P., Surrey, E., Johnson, N. P., Watts, N. B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700089 · Cited by 511
The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices
Rivera, R., Yacobson, I., & Grimes, D. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70120-1 · Cited by 400 · cited 1×
“Combined oral contraceptives (COCs) act by inhibiting follicle-stimulating hormone (FSH) and luteinizing hormone (LH), subsequently blocking follicle development and endometrial proliferation, which is why they were proposed to treat adenomyosis-related symptoms [10].”
BackgroundHorton, J., Sterrenburg, M., Lane, S., Maheshwari, A., Li, T. C., & Cheong, Y. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz012 · Cited by 376 · cited 1×
“Adenomyosis has been repeatedly associated with both poor in vitro fertilization (IVF) outcomes and pregnancy complications [79,80].”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification
Kishi, Y., Suginami, H., Kuramori, R., Yabuta, M., Suginami, R., & Taniguchi, F. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.027 · Cited by 301 · cited 1×
“[20]) may be more prone to developing serious menorrhagia upon dienogest administration than other disease subtypes [21].”
BackgroundGnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Maggi, R., Cariboni, A. M., Marelli, M. M., Moretti, R. M., Andrè, V., Marzagalli, M., & Limonta, P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv059 · Cited by 269 · cited 2×
“These molecules antagonize GnRH binding to its receptors, leading to dose-dependent suppression of FSH and LH and a subsequent decline in ovarian steroids [15,41].”
Background
Research works printed but not linked: 3
- Fujishita, 2010, Shikyusenkinsho to shikyu no onzon-chiryo. Uterine adenomyosis and uterine preservation treatment, J. Obstet. Gynecol. Pract., 59, 769
- Osada, 2017, Shikyukin furappuho niyoru shikyu-senkinsho tekishutsujutsu: Rinshoteki choki-yogo oyobi shikyuharetsu-yobokoka no kento. Adenomyomectomy by uterine muscle flap method: Clinical outcome and investigation of the preventive effect on uterine rupture, Obstet. Gynecol., 84, 1303
- Nishida, 2016, Shikyusenkinsho-kakushutsujutsu-go ninshin-ji no shikyuharetsu-yobo ni tsuite (Prevention of uterine rupture during pregnancy after adenomyomectomy), Obstet. Gynecol. Surg., 27, 69
Cited by
Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology
Guo, S. (2022) · Reproduction · doi:10.1530/rep-22-0224 · Cited by 100
Endometriosis and adenomyosis: Similarities and differences
Donnez, J., Stratopoulou, C. A., & Dolmans, M.-M. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102432 · Cited by 57
Self-citationAdenomyosis and Adolescence: A Challenging Diagnosis and Complex Management
Martire, F. G., d’Abate, C., Schettini, G., Cimino, G., Ginetti, A., Colombi, I., Cannoni, A., Centini, G., Zupi, E., & Lazzeri, L. (2024) · Diagnostics · doi:10.3390/diagnostics14212344 · Cited by 45
“Differentiating these from benign conditions like adenomyosis requires careful imaging and, in some cases, histopathological evaluation [37,78].”
BackgroundSztachelska, M., Ponikwicka‐Tyszko, D., Martínez-Rodrigo, L., Bernaczyk, P., Palak, E., Półchłopek, W., Bielawski, T., & Wołczyński, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154407 · Cited by 41
Stratopoulou, C. A., Cussac, S., d'Argent, M., Donnez, J., & Dolmans, M. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.01.001 · Cited by 38
Self-citation
Metadata
- Authors
- Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M.
- Affiliations
- UCLouvain (BE)
- Cliniques Universitaires Saint-Luc (BE)
- Corresponding author
- Dolmans, Marie-Madeleine
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-10-22
- Volume
- 10
- Issue
- 21
- Pages
- 4878
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC8584979
- OpenAlex
- W3210890914
- Cited by
- 62
- References
- 103
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 13 · 2023: 18 · 2022: 9 · 2021: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fonds National de la Recherche Scientifique de Belgique (5/4/150/5)
- PregLem via the Fondation Saint-Luc (N/A)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Keywords
- uterine adenomyosis, conservative treatment, medical management, surgical management, fertility preservation, hysterectomy, menorrhagia, pelvic pain, infertility, nulliparous women, uterine rupture, GnRH antagonist, off-label drug use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Conservative Management of Uterine Adenomyosis: Medical vs. Surgical Approach. https://app.cochat.ai/papers/10.3390/jcm10214878
- The paper
- Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M. (2021). Conservative Management of Uterine Adenomyosis: Medical vs. Surgical Approach. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10214878
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.